{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:03:44Z","timestamp":1774314224291,"version":"3.50.1"},"reference-count":25,"publisher":"Japanese Society of Toxicology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2131\/jts.40.787","type":"journal-article","created":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T22:06:13Z","timestamp":1447106773000},"page":"787-796","source":"Crossref","is-referenced-by-count":7,"title":["Dose-dependent difference of nuclear receptors involved in murine liver hypertrophy by piperonyl butoxide"],"prefix":"10.2131","volume":"40","author":[{"given":"Yohei","family":"Sakamoto","sequence":"first","affiliation":[{"name":"Division of Pathology, National Institute of Health Sciences"},{"name":"Toxicology Research Department, Pharmaceutical Development Research Laboratories, Teijin Pharma Limited"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Division of Pathology, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Tamura","sequence":"additional","affiliation":[{"name":"Division of Pathology, National Institute of Health Sciences"},{"name":"Toxicology Research Department, Pharmaceutical Development Research Laboratories, Teijin Pharma Limited"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Pathology, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Kodama","sequence":"additional","affiliation":[{"name":"Division of Toxicology, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Inoue","sequence":"additional","affiliation":[{"name":"Division of Pathology, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Adams, N.H., Levi, P.E. and Hodgson, E. (1993): Regulation of cytochrome P-450 isozymes by methylenedioxyphenyl compounds. Chem. Biol. Interact., <b>86<\/b>, 255-274.","DOI":"10.1016\/0009-2797(93)90101-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bercu, J.P., Jolly, R.A., Flagella, K.M., Baker, T.K., Romero, P. and Stevens, J.L. (2010): Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens. Regul. Toxicol. Pharmacol., <b>58<\/b>, 369-381.","DOI":"10.1016\/j.yrtph.2010.08.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Boobis, A.R., Daston, G.P., Preston, R.J. and Olin, S.S. (2009): Application of key events analysis to chemical carcinogens and noncarcinogens. Crit. Rev. Food. Sci. Nutr., <b>49<\/b>, 690-707.","DOI":"10.1080\/10408390903098673"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Fujitani, T., Tanaka, T., Hashimoto, Y. and Yoneyama, M. (1993): Subacute toxicity of piperonyl butoxide in ICR mice. Toxicology, <b>83<\/b>, 93-100.","DOI":"10.1016\/0300-483X(93)90094-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Goetz, A.K., Singh, B.P., Battalora, M., Breier, J.M., Bailey, J.P., Chukwudebe, A.C. and Janus, E.R. (2011): Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications. Regul. Toxicol. Pharmacol., <b>61<\/b>, 141-153.","DOI":"10.1016\/j.yrtph.2011.07.012"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Holsapple, M.P., Pitot, H.C., Cohen, S.M., Boobis, A.R., Klaunig, J.E., Pastoor, T., Dellarco, V.L. and Dragan, Y.P. (2006): Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol. Sci., <b>89<\/b>, 51-56.","DOI":"10.1093\/toxsci\/kfj001"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Kodama, S., Koike, C., Negishi, M. and Yamamoto, Y. (2004): Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol. Cell. Biol., <b>24<\/b>, 7931-7940.","DOI":"10.1128\/MCB.24.18.7931-7940.2004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"LeCluyse, E.L. (2001): Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics. Chem. Biol. Interact., <b>134<\/b>, 283-289.","DOI":"10.1016\/S0009-2797(01)00163-6"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Maglich, J.M., Stoltz, C.M., Goodwin, B., Hawkins-Brown, D., Moore, J.T. and Kliewer, S.A. (2002): Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol. Pharmacol., <b>62<\/b>, 638-646.","DOI":"10.1124\/mol.62.3.638"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Morita, R., Yafune, A., Shiraki, A., Itahashi, M., Akane, H., Nakane, F., Suzuki, K., Shibutani, M. and Mitsumori, K. (2013): Suppressive effect of liver tumor-promoting activities in rats subjected to combined administration of phenobarbital and piperonyl butoxide. J. Toxicol. Sci., <b>38<\/b>, 679-688.","DOI":"10.2131\/jts.38.679"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Muguruma, M., Nishimura, J., Jin, M., Kashida, Y., Moto, M., Takahashi, M., Yokouchi, Y. and Mitsumori, K. (2006): Molecular pathological analysis for determining the possible mechanism of piperonyl butoxide-induced hepatocarcinogenesis in mice. Toxicology, <b>228<\/b>, 178-187.","DOI":"10.1016\/j.tox.2006.08.029"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Okamiya, H., Mitsumori, K., Onodera, H., Ito, S., Imazawa, T., Yasuhara, K. and Takahashi, M. (1998): Mechanistic study on liver tumor promoting effects of piperonyl butoxide in rats. Arch. Toxicol., <b>72<\/b>, 744-750.","DOI":"10.1007\/s002040050569"},{"key":"13","unstructured":"Quattrochi, L.C. and Guzelian, P.S. (2001): Cyp3A regulation: from pharmacology to nuclear receptors. Drug Metab. Dispos., <b>29<\/b>, 615-622."},{"key":"14","doi-asserted-by":"crossref","unstructured":"Ryu, D.Y., Levi, P.E., Fernandez-Salguero, P., Gonzalez, F.J. and Hodgson, E. (1996): Piperonyl butoxide and acenaphthylene induce cytochrome P450 1A2 and 1B1 mRNA in aromatic hydrocarbon-responsive receptor knock-out mouse liver. Mol. Pharmacol., <b>50<\/b>, 443-446.","DOI":"10.1016\/S0026-895X(25)09289-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Sakamoto, Y., Inoue, K., Takahashi, M., Taketa, Y., Kodama, Y., Nemoto, K., Degawa, M., Gamou, T., Ozawa, S., Nishikawa, A. and Yoshida, M. (2013): Different pathways of constitutive androstane receptor-mediated liver hypertrophy and hepatocarcinogenesis in mice treated with Piperonyl butoxide or decabromodiphenyl ether. Toxicol. Pathol., <b>41<\/b>, 1078-1092.","DOI":"10.1177\/0192623313482055"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Takahashi, O., Ohishi, S., Fujitani, T., Tanaka, T. and Yoneyama, M. (1994): Chronic toxicity studies of piperonyl butoxide in F344 rats: Induction of hepatocellular carcinoma. Fundam. Appl. Toxicol.,<b> 22<\/b>, 293-303.","DOI":"10.1006\/faat.1994.1033"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Takahashi, O., Oishi, S., Fujitani, T., Tanaka, T. and Yoneyama, M. (1997): Chronic toxicity studies of piperonyl butoxide in CD-1 mice: Induction of hepatocellular carcinoma. Toxicology, <b>124<\/b>, 95-103.","DOI":"10.1016\/S0300-483X(97)00136-4"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Tamasi, V., Juvan, P., Beer, M., Rozman, D. and Meyer, U.A. (2009): Transcriptional activation of PPARalpha by phenobarbital in the absence of CAR and PXR. Mol. Pharm., <b>6<\/b>, 1573-1581.","DOI":"10.1021\/mp9001552"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Tamura, K., Inoue, K., Takahashi, M., Matsuo, S., Irie, K., Kodama, Y., Ozawa, S., Nishikawa, A. and Yoshida, M. (2013): Dose-response involvement of constitutive androstane receptor in mouse liver hypertrophy induced by triazole fungicides. Toxicol. Lett., <b>221<\/b>, 47-56.","DOI":"10.1016\/j.toxlet.2013.05.011"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Tasaki, M., Umemura, T., Suzuki, Y., Hibi, D., Inoue, T., Okamura, T., Ishii, Y., Maruyama, S., Nohmi, T. and Nishikawa, A. (2010): Oxidative DNA damage and reporter gene mutation in the livers of gpt delta rats given non-genotoxic hepatocarcinogens with cytochrome P450-inducible potency. Cancer Sci., <b>101<\/b>, 2525-2530.","DOI":"10.1111\/j.1349-7006.2010.01705.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Ueda, A., Hamadeh, H.K., Webb, H.K., Yamamoto, Y., Sueyoshi, T., Afshari, C.A., Lehmann, J.M. and Negishi, M. (2002): Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol. Pharmacol., <b>61<\/b>, 1-6.","DOI":"10.1124\/mol.61.1.1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Watanabe, T., Manabe, S., Ohashi, Y., Okamiya, H., Onodera, H. and Mitsumori, K. (1998): Comparison of the induction profile of hepatic drug-metabolizing enzymes between piperonyl butoxide and phenobarbital in rats. J. Toxicol. Pathol., <b>11<\/b>, 1-10.","DOI":"10.1293\/tox.11.1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Whysner, J., Ross, P.M. and Williams, G.M. (1996): Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol. Ther.,<b> 71<\/b>, 153-191.","DOI":"10.1016\/0163-7258(96)00067-8"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Xie, W., Barwick, J.L., Simon, C.M., Pierce, A.M., Safe, S., Blumberg, B., Guzelian, P.S. and Evans, R.M. (2000): Reciprocal activation of xenobiotic response genes by nuclear receptors SXR\/PXR and CAR. Genes Dev., <b>14<\/b>, 3014-3023.","DOI":"10.1101\/gad.846800"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Yamamoto, Y., Moore, R., Goldsworthy, T.L., Negishi, M. and Maronpot, R.R. (2004): The orphan nuclear receptor constitutive active\/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res., <b>64<\/b>, 7197-7200.","DOI":"10.1158\/0008-5472.CAN-04-1459"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/40\/6\/40_787\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T10:42:39Z","timestamp":1748688159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/40\/6\/40_787\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.40.787","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}